Skip to content
Brand AI

Shinva Medical Instrument Co., Ltd.

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2017

    Failure to timely disclose earnings forecast and M&A performance compensation dispute

    In 2017, Shinva Medical failed to timely disclose a sharp decline in performance and was issued a warning letter by the Shandong Securities Regulatory Bureau; after acquiring Chengdu Yingde, its performance commitments missed targets for consecutive years, the original shareholders failed to compensate in time and were criticized by the Shanghai Stock Exchange, and Shinva Medical did not receive full support in the compensation litigation. Warning letter; litigation.

    Source